Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pirfenidone in Idiopathic Pulmonary Fibrosis
NCT02136992Phase 2Completed
- Sponsor
- Shanghai Pulmonary Hospital
- Start
- Dec 2011
- Primary completion
- Jun 2013
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of pirfenidone in idiopathic pulmonary fibrosis (IPF), sponsored by Shanghai Pulmonary Hospital. Started Dec 2011; status: completed.
02
Drugs
pirfenidone
03
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on NCT02136992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02136992.